The toxic actions of MPTP and its metabolite MPP+ are not mimicked by analogues of MPTP lacking an N-methyl moiety
Authors:
- A.J. BradburyABA.J. Bradbury
- B. CostallBCB. Costall
- A.M. DomeneyADA.M. Domeney
- B. TestaBTB. Testa
- P.G. JennerPJP.G. Jenner
- C.D. MarsdenCMC.D. Marsden
- R.J. NaylorRNR.J. Naylor
- 1 October 1985
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 61 (1-2) , 121-126
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- V. Potential bioactivation pathways for the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)Life Sciences, 1985
- Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitorsNature, 1984
- Pargyline and deprenyl prevent the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in monkeysEuropean Journal of Pharmacology, 1984
- Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonismNature, 1984
- Pargyline Prevents MPTP-Induced Parkinsonism in PrimatesScience, 1984
- The importance of the ‘4–5’ double bond for neurotoxicity in primates of the pyridine derivative MPTPNeuroscience Letters, 1984
- High-affinity binding sites for [3H]MPTP may correspond to monamine oxidaseEuropean Journal of Pharmacology, 1984
- The Neurotoxicity of 1-Methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine in the Monkey and ManCanadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 1984
- Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkeyBrain Research, 1984
- Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog SynthesisScience, 1983